32 results on '"Qi ZHOU"'
Search Results
2. Correlation of CT-derived pectoralis muscle status and COVID-19 induced lung injury in elderly patients
- Author
-
Ying-hao, Pei, Hai-dong, Zhang, Yuan, Fang, Yong-kang, Liu, Sen, Liang, Wei-long, Xu, Yu-shan, Yang, Jun-feng, Zhu, Hai-qi, Zhou, and Hua, Jiang
- Published
- 2022
- Full Text
- View/download PDF
3. Visual appearance of the uterine cervix differs on the basis of HPV type status in high-grade squamous intraepithelial lesion: the results of a reliable method
- Author
-
Qi Zhou, Yingxin Gong, Xiangmei Qiu, Long Sui, Hongwei Zhang, Yan Wang, Lin Lin, Wenjing Diao, and Yanyun Li
- Subjects
Human papillomavirus (HPV) ,Human papillomavirus 16 ,Genotype ,Research ,Squamous Intraepithelial Lesions ,Papillomavirus Infections ,Obstetrics and Gynecology ,Uterine Cervical Neoplasms ,General Medicine ,Gynecology and obstetrics ,ImageJ ,Reproductive Medicine ,Colposcopy ,RG1-991 ,Cervical cancer ,Carcinoma, Squamous Cell ,Humans ,Female ,Prospective Studies ,Public aspects of medicine ,RA1-1270 ,Papillomaviridae ,High-grade squamous intraepithelial lesion (HSIL) ,Carcinoma in Situ ,Iodine - Abstract
Background This study aimed to evaluate the differences in cervical appearance among different human papillomavirus (HPV) genotypes in patients with high-grade squamous intraepithelial lesions (HSILs). Methods A total of 239 histopathological HSIL patients were included and divided into eight groups on the basis of HPV genotype in this prospective study. We present a reliable imaging method that provides reproducible, sensitive and unbiased assessments of cervical appearance characteristics. Colorimetric and morphometric data of colposcopic patterns after the application of acetic acid and iodine were acquired using ImageJ software and the surrounding normal regions were used as controls. Results The differences in red, green, blue and mean greyscale values in acetowhite epithelium obtained from ImageJ were not significant between the HPV16 and HPV18 groups (P < 0.05). The differences in red, green, and mean greyscale values in iodine staining were significant between the HPV18 and the other groups (P < 0.05). The frequency of the occurrence of the coarse mosaic patterns was significantly different among groups (P < 0.05), reducing in sequence were the HPV16, HPV-negative, HPV18, HPV31/33 and HPV52/58 groups. For the lesion area of HSILs, the HPV-negative group was the largest. The sensitivity of colposcopic impression varied among HPV genotypes (P < 0.01), being lowest in the HPV52 group. Conclusions Although being nonspecific, iodine negativity should be concerned in HPV18-positive lesions which is closely related to glandular epithelium. Vascular patterns in HPV52/58-positive HSIL are quite occult and tend to be missed by colposcopists. HPV-negative lesions are prone to be large and present typical vascular patterns despite being rare.
- Published
- 2022
4. Methodology and experiences of rapid advice guideline development for children with COVID-19: responding to the COVID-19 outbreak quickly and efficiently
- Author
-
Qi Zhou, Qinyuan Li, Janne Estill, Qi Wang, Zijun Wang, Qianling Shi, Jingyi Zhang, Xiaobo Zhang, Joseph L. Mathew, Rosalind L. Smyth, Detty Nurdiati, Zhou Fu, Hongmei Xu, Xianlan Zheng, Xiaodong Zhao, Quan Lu, Hui Liu, Yangqin Xun, Weiguo Li, Shu Yang, Xixi Feng, Mengshu Wang, Junqiang Lei, Xiaoping Luo, Liqun Wu, Xiaoxia Lu, Myeong Soo Lee, Shunying Zhao, Edwin Shih-Yen Chan, Yuan Qian, Wenwei Tu, Xiaoyan Dong, Guobao Li, Ruiqiu Zhao, Zhihui He, Siya Zhao, Xiao Liu, Qiu Li, Kehu Yang, Zhengxiu Luo, Enmei Liu, and Yaolong Chen
- Subjects
510 Mathematics ,Epidemiology ,360 Social problems & social services ,COVID-19 ,Humans ,Health Informatics ,Guidelines as Topic ,Public Health ,Child ,Disease Outbreaks - Abstract
Background Rapid Advice Guidelines (RAG) provide decision makers with guidance to respond to public health emergencies by developing evidence-based recommendations in a short period of time with a scientific and standardized approach. However, the experience from the development process of a RAG has so far not been systematically summarized. Therefore, our working group will take the experience of the development of the RAG for children with COVID-19 as an example to systematically explore the methodology, advantages, and challenges in the development of the RAG. We shall propose suggestions and reflections for future research, in order to provide a more detailed reference for future development of RAGs. Result The development of the RAG by a group of 67 researchers from 11 countries took 50 days from the official commencement of the work (January 28, 2020) to submission (March 17, 2020). A total of 21 meetings were held with a total duration of 48 h (average 2.3 h per meeting) and an average of 16.5 participants attending. Only two of the ten recommendations were fully supported by direct evidence for COVID-19, three recommendations were supported by indirect evidence only, and the proportion of COVID-19 studies among the body of evidence in the remaining five recommendations ranged between 10 and 83%. Six of the ten recommendations used COVID-19 preprints as evidence support, and up to 50% of the studies with direct evidence on COVID-19 were preprints. Conclusions In order to respond to public health emergencies, the development of RAG also requires a clear and transparent formulation process, usually using a large amount of indirect and non-peer-reviewed evidence to support the formation of recommendations. Strict following of the WHO RAG handbook does not only enhance the transparency and clarity of the guideline, but also can speed up the guideline development process, thereby saving time and labor costs.
- Published
- 2022
- Full Text
- View/download PDF
5. Unveiling the factors shaping teacher job performance: exploring the interplay of personality traits, perceived organizational support, self-efficacy, and job satisfaction
- Author
-
Li, Lina, Kanchanapoom, Kessara, Deeprasert, Jirawan, Duan, Ninggui, and Qi, Zhou
- Published
- 2025
- Full Text
- View/download PDF
6. Correction to: The role of microRNA-133b and its target gene FSCN1 in gastric cancer
- Author
-
Hua Bai, Qi Zhou, Tao Hong, Jiaqiang Huang, Jin-Sheng He, Pengfei He, Dongling Zou, Lihua Guo, and Jie Liu
- Subjects
Cancer Research ,business.industry ,MEDLINE ,Cancer ,Correction ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,medicine.disease ,lcsh:RC254-282 ,Text mining ,Oncology ,microRNA ,Cancer research ,Medicine ,Target gene ,business - Abstract
An amendment to this paper has been published and can be accessed via the original article.
- Published
- 2020
7. Gut bacteria Akkermansia is associated with reduced risk of obesity: evidence from the American Gut Project
- Author
-
Chen Chen, Liang Sun, Ying Zhang, Ruiyue Yang, Huiping Yuan, Xiaoxia Wang, Ze Yang, Xiaoquan Zhu, Qi Zhou, and Yanfeng Zhang
- Subjects
Endocrinology, Diabetes and Metabolism ,Population ,Medicine (miscellaneous) ,Physiology ,lcsh:TX341-641 ,Clinical nutrition ,Gut microbiota ,Gut flora ,03 medical and health sciences ,Medicine ,Obesity ,16S rRNA ,education ,lcsh:RC620-627 ,Body mass index ,030304 developmental biology ,0303 health sciences ,education.field_of_study ,Nutrition and Dietetics ,biology ,030306 microbiology ,business.industry ,Research ,Probiotics ,Confounding ,Akkermansia ,Odds ratio ,biology.organism_classification ,medicine.disease ,lcsh:Nutritional diseases. Deficiency diseases ,business ,lcsh:Nutrition. Foods and food supply - Abstract
Background Gut bacteria Akkermansia has been shown an anti-obesity protective effect in previous studies and may be used as promising probiotics. However, the above effect may be confounded by common factors, such as sex, age and diets, which should be verified in a generalized population. Methods We used datasets from the American Gut Project to strictly reassess the association and further examined the effect of aging on it. A total of 10,534 participants aged 20 to 99 years from the United States and the United Kingdom were included. The relative abundance of Akkermansia was assessed based on 16S rRNA sequencing data. Obesity (body mass index, BMI ≥ 30 kg/m2) risks were compared across Akkermansia quintiles in logistic models with adjustment for common confounders. Restricted cubic splines were used to examine dose response effects between Akkermansia, obesity and age. A sliding-windows-based algorithm was used to investigate the effect of aging on Akkermansia-obesity associations. Results The median abundance of Akkermansia was 0.08% (interquartile range: 0.006–0.93%), and the prevalence of obesity was 11.03%. Nonlinear association was detected between Akkermansia and obesity risk (P = 0.01). The odds ratios (95% confidence interval) for obesity across the increasing Akkermansia quintiles (referencing to the first quintile) were 1.14 (0.94–1.39), 0.94 (0.77–1.15), 0.70 (0.56–0.85) and 0.79 (0.64–0.96) after adjusting for age and sex (P for trend Akkermansia were 0.19 (0.03–0.62) and 0.77 (0.64–0.91) before and over 40 years, respectively, indicating that the protective effect of Akkermansia against obesity was not stable with aging. Conclusion High relative abundance of Akkermansia is associated with low risk of obesity and the association declines with aging.
- Published
- 2020
8. Using RIGHT (Reporting Items for Practice Guidelines in Healthcare) to evaluate the reporting quality of WHO guidelines
- Author
-
Susan L Norris, Yaolong Chen, Yujie Xiao, Liang Yao, Yajing Tong, Xiaoqin Wang, Kehu Yang, Nan Yang, Kevin Pottie, Qi Wang, and Qi Zhou
- Subjects
medicine.medical_specialty ,Practice guideline ,Reporting quality ,030204 cardiovascular system & hematology ,World Health Organization ,RIGHT (Reporting Items for Practice Guidelines in HealThcare) ,Health administration ,03 medical and health sciences ,WHO ,0302 clinical medicine ,Health care ,medicine ,Humans ,030212 general & internal medicine ,Grading (education) ,Health policy ,Language ,Descriptive statistics ,business.industry ,Health Policy ,Public health ,lcsh:Public aspects of medicine ,Research ,Health services research ,lcsh:RA1-1270 ,Checklist ,Family medicine ,Health Facilities ,business ,Delivery of Health Care - Abstract
Background Without adequate reporting of research, valuable time and resources are wasted. In the same vein, adequate reporting of practice guidelines to optimise patient care is equally important. Our study examines the quality of reporting of published WHO guidelines, over time, using the RIGHT (Reporting Items for Practice Guidelines in HealThcare) reporting checklist. Methods We examined English-language guidelines approved by the WHO Guidelines Review Committee from inception of the committee in 2007 until 31 December 2017. Pairs of independent, trained reviewers assessed the reporting quality of these guidelines. Descriptive data were summarised with frequencies and percentages. Results We included 182 eligible guidelines. Overall, 25 out of the 34 RIGHT items were reported in 75% or more of the WHO guidelines. The reporting rates improved over time. Further, 90% of the guidelines reported document type in the title. The identification of evidence, the rationale for recommendations and the review process were reported in more than 80% of guidelines. The certainty of the evidence using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system was assessed in 81% of the guidelines assessed. While 82% of guidelines reported funding sources, only 25% mentioned the role of funders. Conclusions WHO guidelines provide adequate reporting of many of the RIGHT items and reporting has improved over time. WHO guidelines compare favourably to guidelines produced by other organisations. However, reporting can be further improved in a number of areas.
- Published
- 2020
9. Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma
- Author
-
Wan Ming Hu, Ling Guo, Yan Tang, Jing Jing Zhao, Ai Lin Zhong, Meng Jia Song, Jian Chuan Xia, Qiu Zhong Pan, Gang Ma, Ming Yuan Chen, Chao Pin Yang, Tong Xiang, Yuan Liu, De Sheng Weng, Min Li, Qian Zhu, Hao Hu, Jie Ying Yang, Jun Yi He, and Zi Qi Zhou
- Subjects
0301 basic medicine ,Male ,Cancer Research ,Biology ,urologic and male genital diseases ,lcsh:RC254-282 ,PI3K ,03 medical and health sciences ,Phosphatidylinositol 3-Kinases ,0302 clinical medicine ,Cell Line, Tumor ,AGK ,Humans ,Epithelial–mesenchymal transition ,Neoplasm Metastasis ,Molecular Biology ,Protein kinase B ,Carcinoma, Renal Cell ,PI3K/AKT/mTOR pathway ,Glycogen Synthase Kinase 3 beta ,Oncogene ,lcsh:RC633-647.5 ,Kinase ,Research ,AKT ,lcsh:Diseases of the blood and blood-forming organs ,Hematology ,Cell cycle ,Middle Aged ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Epithelial-mesenchymal transition ,Hedgehog signaling pathway ,female genital diseases and pregnancy complications ,Renal cell carcinoma ,Kidney Neoplasms ,Enzyme Activation ,Phosphotransferases (Alcohol Group Acceptor) ,030104 developmental biology ,Oncology ,030220 oncology & carcinogenesis ,Cancer research ,Disease Progression ,Female ,Acylglycerol kinase ,Proto-Oncogene Proteins c-akt ,Signal Transduction - Abstract
Background Clinically, the median survival in patients with metastatic renal cell carcinoma (RCC) was only 6–12 months and a 5-year survival rate of less than 20%. Therefore, an in-depth study of the molecular mechanisms involved in RCC is of great significance for improving the survival of patients with advanced RCC. Acylglycerol kinase (AGK) is a newly discovered lipid kinase that has been reported to be a potent oncogene that may be involved in the regulation of malignant progression in a variety of tumours. However, the expression and biological characteristics of the AGK gene in RCC remain unclear. Methods AGK expression was quantified by quantitative real-time PCR, Western blotting and immunohistochemistry in RCC cell lines and paired patient tissues. Kaplan-Meier method and Cox proportional hazards models were used to evaluate the prognostic value of AGK in human RCC tissue samples. Chi-squared test was performed to analyse the correlation between AGK expression and the clinicopathological features. Stable overexpression and knockdown of AGK in RCC cells was constructed with lentivirus. The oncogenic effects of AGK in human RCC progression were investigated using assays of colony formation, anchorage-independent growth, EdU assay, cell cycle analysis, wound-healing, trans-well analysis and xenograft tumour model. GSEA and KEGG analysis were conducted to detect the potential pathway of AGK involved in RCC. These results were further confirmed using the luciferase reporter assays, immunofluorescence and in vivo experiments. Results AGK expression is significantly elevated in RCC and closely related to the malignant development and poor prognosis in RCC patients. By in vitro and in vivo experiments, AGK was shown to enhance the proliferation of RCC cells by promoting the transition from the G1 phase to the S phase in the cell cycle and to enhance the migration and invasion by promoting epithelial-mesenchymal transition. By activating the PI3K/AKT/GSK3β signalling pathway in RCC, AGK can increase nuclear accumulation of β-catenin, which further upregulated TCF/LEF transcription factor activity. Conclusions AGK promotes the progression of RCC via activating the PI3K/AKT/GSK3β signalling pathway and might be a potential target for the further research of RCC.
- Published
- 2020
10. The m6A eraser FTO facilitates proliferation and migration of human cervical cancer cells
- Author
-
Dongling Zou, Lei Dong, Zhe Yin, Chenying Li, Shuan Rao, and Qi Zhou
- Subjects
Cancer Research ,Translation ,endocrine system diseases ,Demethylase ,Myc ,medicine.disease_cause ,lcsh:RC254-282 ,HeLa ,Small hairpin RNA ,03 medical and health sciences ,0302 clinical medicine ,Demethylase activity ,Genetics ,medicine ,E2F1 ,lcsh:QH573-671 ,030304 developmental biology ,0303 health sciences ,biology ,lcsh:Cytology ,Cell growth ,Correction ,nutritional and metabolic diseases ,Translation (biology) ,pathological conditions, signs and symptoms ,m6A ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,biology.organism_classification ,Oncology ,030220 oncology & carcinogenesis ,biology.protein ,Cancer research ,Carcinogenesis ,Primary Research ,FTO - Abstract
Background Since FTO was recognized as the first m6A demethylase, the understanding of its biological function has been widely expanded. However, the role of FTO in cervical cancer tumorigenesis remains unclear. Methods In this study, we first analyzed the expression of FTO in two independent human cancer datasets and evaluated the correlation between FTO level and cervical cancer progression. Using small hairpin RNA technology, we explored the function of FTO in cervical cancer cell line Hela and SiHa cells, respectively. We then determined the FTO targets by performing transcriptional profile with FTO deficient and competent Hela cells, and finally validated these targets with ribosome profiling and functional rescue experiments. Results Our data suggested that FTO was frequently overexpressed in human cervical cancer tissues and highly correlated with cervical cancer progression. FTO serves as an oncogenic regulator for cervical cancer cells’ proliferation and migration which is vastly depended on its demethylase activity. Mechanistically, FTO interacts with transcripts of E2F1 and Myc, inhibition of FTO significantly impairs the translation efficiency of E2F1 and Myc, however, either overexpress E2F1 or Myc sufficiently compensates the FTO deficiency which decreases cell proliferation and migration. Conclusions Our study indicates that FTO plays important oncogenic role in regulating cervical cancer cells’ proliferation and migration via controlling m6A modification of E2F1 and Myc transcripts. FTO represents a potential drug candidate for cervical cancer therapy.
- Published
- 2019
11. The effect of low insurance reimbursement on quality of care for non-small cell lung cancer in China: a comprehensive study covering diagnosis, treatment, and outcomes
- Author
-
Jiaying Wang, Qi Zhou, Shaofei Su, Xi Li, Meina Liu, Hao Jiang, Meiqi Zhang, and Xinyu Wang
- Subjects
Adult ,Male ,Cancer Research ,medicine.medical_specialty ,Lung Neoplasms ,medicine.medical_treatment ,Quality indicators ,Logistic regression ,lcsh:RC254-282 ,Insurance reimbursement rate ,Odds ,03 medical and health sciences ,0302 clinical medicine ,Pharmacotherapy ,Non-small cell lung cancer ,Carcinoma, Non-Small-Cell Lung ,Health care ,Genetics ,Medicine ,Humans ,030212 general & internal medicine ,Healthcare Disparities ,Intensive care medicine ,Lung cancer ,Reimbursement ,Aged ,Quality of Health Care ,business.industry ,Middle Aged ,medicine.disease ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Diagnosis, treatment, and outcomes ,Radiation therapy ,Logistic Models ,Oncology ,030220 oncology & carcinogenesis ,Cohort ,Insurance, Health, Reimbursement ,Female ,business ,Research Article - Abstract
Background The insurance reimbursement rate of medical cost affects the quality and quantity of health services provided in China. The nature of this relationship, however, has not been reliably described in the field of non-small cell lung cancer (NSCLC). The objective of the current study was to examine the impact of low reimbursement rates of medical costs on diagnosis, treatment and outcomes among patients with NSCLC. Methods We examined care of 2643 NSCLC patients and we divided the study cohort into a high reimbursement rate group and a low reimbursement rate group. The impact of reimbursement rates of medical costs on quality of care of NSCLC patients were examined using logistic regression and generalized linear models. Results Compared with patients insured with high reimbursement rate, patients insured through lower reimbursement rate programs were less likely to benefit from early detection and treatment services. Delayed detection was more common in low reimbursement group and they were less likely to be recommended for adjuvant chemotherapy, or to receive adjuvant chemotherapy and postoperative radiation therapy and they had lower odds to receipt chemotherapy response assessment. However, low reimbursement rate group had lower rate of in-hospital mortality and metastases. Conclusions Low reimbursement rate mainly negatively influenced the diagnosis and treatment of NSCLC. Reducing the gap in reimbursement rate between the three health insurance schemes should be a focus of equalizing access to care and improving the level of medical compliance and finally improving quality of care of NSCLC. Electronic supplementary material The online version of this article (10.1186/s12885-018-4608-y) contains supplementary material, which is available to authorized users.
- Published
- 2018
12. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer
- Author
-
Ying Zhang, Guihai Feng, Wei Li, Qi Zhou, Fei Teng, Lu Guo, and Yuhuan Li
- Subjects
0301 basic medicine ,Male ,Cancer Research ,Colorectal cancer ,medicine.disease_cause ,miR-494 ,0302 clinical medicine ,Wnt Signaling Pathway ,biology ,microRNA ,Wnt signaling pathway ,Middle Aged ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Prognosis ,Gene Expression Regulation, Neoplastic ,Cell Transformation, Neoplastic ,Oncology ,Adenomatous Polyposis Coli ,030220 oncology & carcinogenesis ,Disease Progression ,Molecular Medicine ,Female ,RNA Interference ,Signal transduction ,Colorectal Neoplasms ,Adult ,Adenomatous polyposis coli ,lcsh:RC254-282 ,03 medical and health sciences ,Cell Line, Tumor ,medicine ,Biomarkers, Tumor ,Humans ,Aged ,Cell Proliferation ,Neoplasm Staging ,Cell growth ,Research ,Gene Expression Profiling ,Cancer ,medicine.disease ,Apc ,MicroRNAs ,030104 developmental biology ,Mutation ,biology.protein ,Cancer research ,Neoplasm Grading ,Carcinogenesis - Abstract
Background Aberrant activation of the Wnt/β-catenin signaling pathway is frequently observed in colorectal cancer (CRC). β-catenin is the major Wnt signaling pathway effector and inactivation of adenomatous polyposis coli (APC) results in nuclear accumulation of β-catenin. It has been suggested that inactivation of APC plays an important role in activation of the Wnt/β-catenin pathway and in the progression of colorectal tumorigenesis. However, the mechanism through which APC mediates colorectal tumorigenesis is not understood. Increasing evidence suggests that the dysregulation of microRNAs (miRNAs) is involved in colorectal tumorigenesis. Although miR-494 has been reported as being an upregulated miRNA, the interplay between miR-494 and APC-mediated colorectal tumorigenesis progression remains unclear. Methods The expression of miR-494 in tissues from patients diagnosed with CRC was analyzed using a microarray and real-time PCR. The effects of miR-494 on cell proliferation and tumorigenesis in CRC cells were analyzed by flow cytometry, colony formation assays, BrdU incorporation assays, and CCK8 assays. The correlation between miR-494 expression and APC expression, as well as the mechanisms by which miR-494 regulates APC in CRC were also addressed. Results miR-494 was significantly upregulated in CRC tissues, and this increase was negatively associated with APC expression. APC was confirmed to be a direct target of miR-494 in CRC. Furthermore, overexpression of miR-494 induced Wnt/β-catenin signaling by targeting APC, thus promoting CRC cell growth. Conclusions This study provides novel insights into the role of miR-494 in controlling CRC cell proliferation and tumorigenesis, and identifies miR-494 as a potential prognostic marker and therapeutic target.
- Published
- 2018
13. Pooled safety analyses of ALK-TKI inhibitor in ALK-positive NSCLC.
- Author
-
Qian Zhu, Hao Hu, De-Sheng Weng, Xiao-Fei Zhang, Chang-Long Chen, Zi-Qi Zhou, Yan Tang, Jian-Chuan Xia, Zhu, Qian, Hu, Hao, Weng, De-Sheng, Zhang, Xiao-Fei, Chen, Chang-Long, Zhou, Zi-Qi, Tang, Yan, and Xia, Jian-Chuan
- Subjects
CANCER treatment ,NON-small-cell lung carcinoma ,ANAPLASTIC lymphoma kinase ,PROTEIN-tyrosine kinase inhibitors ,ADVERSE health care events ,CRIZOTINIB ,DRUG toxicity ,THERAPEUTICS ,CLINICAL trials ,COMPARATIVE studies ,HETEROCYCLIC compounds ,LUNG cancer ,LUNG tumors ,RESEARCH methodology ,MEDICAL cooperation ,META-analysis ,PATIENT safety ,PIPERIDINE ,PYRIDINE ,RESEARCH ,SULFONES ,TRANSFERASES ,SYSTEMATIC reviews ,EVALUATION research ,PROTEIN kinase inhibitors - Abstract
Background: The anaplastic lymphoma kinase tyrosine kinase inhibitors (ALK-TKIs) have been administered to patients with ALK-positive non-small cell lung cancer for a long period of time and show a promising response. However, the differences in the toxicity profiles among these drugs are still unclear.Methods: We performed a comprehensive search of the MEDLINE, EMBASE, WEB OF SCIENCE and COCHRANE databases from the drugs' inception to May 2016 to identify clinical trials. Severe adverse events (AEs) (grade ≥ 3) based on the ALK-TKI type were analysed.Results: Seventeen trials published between 2011 and 2016, including a total of 1826 patients, were eligible for analysis. Patients in 10 trials (n = 1000) received crizotinib, patients in 5 trials (n = 601) received ceritinib and patients in 2 trials (n = 225) received alectinib. The overall frequencies of treatment-related death and AEs due to treatment withdrawal were 0.9% (12/1365) and 5.5% (85/1543), respectively. Moreover, the frequency of severe AEs in patients treated with ceritinib was significantly higher than patients treated with crizotinib or alectinib, especially for hepatotoxicity, fatigue and some of gastrointestinal symptoms. Additionally, significant difference in the elevated lipase and amylase levels (grade ≥ 3) were detected between ceritinib and crizotinib/alectinib, whereas neutropenia was less frequent.Conclusions: ALK-TKIs were safe for ALK-positive patients. Moreover, statistically significant differences in some severe AEs among ceritinib, crizotinib and alectinib were detected in present study. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
14. Chloroquine inhibits Ca2+ permeable ion channels-mediated Ca2+ signaling in primary B lymphocytes.
- Author
-
Yi-Fan Wu, Ping Zhao, Xi Luo, Jin-Chao Xu, Lu Xue, Qi Zhou, Mingrui Xiong, Jinhua Shen, Yong-Bo Peng, Meng-Fei Yu, Weiwei Chen, Liqun Ma, and Qing-Hua Liu
- Subjects
CHLOROQUINE ,THAPSIGARGIN ,B cells - Abstract
Background: Chloroquine, a bitter tastant, inhibits Ca
2+ signaling, resulting in suppression of B cell activation; however, the inhibitory mechanism remains unclear. Results: In this study, thapsigargin (TG), but not caffeine, induced sustained intracellular Ca2+ increases in mouse splenic primary B lymphocytes, which were markedly inhibited by chloroquine. Under Ca2+- free conditions, TG elicited transient Ca2+ increases, which additionally elevated upon the restoration of 2 mM Ca2+ . The former were from release of intracellular Ca2+ store and the latter from Ca2+ influx. TG-induced release was inhibited by 2-APB (an inhibitor of inositol-3-phosphate receptors, IP3Rs) and chloroquine, and TG-caused influx was inhibited by pyrazole (Pyr3, an inhibitor of transient receptor potential C3 (TRPC3) and stromal interaction molecule (STIM)/Orai channels) and chloroquine. Moreover, chloroquine also blocked Ca2+ increases induced by the engagement of B cell receptor (BCR) with anti-IgM. Conclusions: These results indicate that chloroquine inhibits Ca2+ elevations in splenic B cells through inhibiting Ca2+ permeable IP3R and TRPC3 and/or STIM/Orai channels. These findings suggest that chloroquine would be a potent immunosuppressant. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
15. Methodological survey of designed uneven randomization trials (DU-RANDOM): a protocol
- Author
-
Philip J. Devereaux, Krupesh Patel, Barbara Prediger, Elie A. Akl, Maicon Falavigna, Namrata Patel, Holger J. Schünemann, Darong Wu, Nancy Santesso, Yuan Zhang, Taoying Lu, Qi Zhou, Matthias Briel, Romina Brignardello-Petersen, Gordon H. Guyatt, and Reem A. Mustafa
- Subjects
Research design ,Randomization Ratio ,Randomization ,Medicine (miscellaneous) ,Designed uneven randomization trials ,Statistical power ,Study Protocol ,Informed consent ,Trial participation ,Statistics ,Medicine ,Participation rate ,Humans ,Pharmacology (medical) ,Randomized Controlled Trials as Topic ,Protocol (science) ,Informed Consent ,business.industry ,Patient Selection ,Linear model ,Sample size determination ,Research Design ,Sample Size ,Linear Models ,Journal Impact Factor ,Periodicals as Topic ,business - Abstract
Background Although even randomization (that is, approximately 1:1 randomization ratio in study arms) provides the greatest statistical power, designed uneven randomization (DUR), (for example, 1:2 or 1:3) is used to increase participation rates. Until now, no convincing data exists addressing the impact of DUR on participation rates in trials. The objective of this study is to evaluate the epidemiology and to explore factors associated with DUR. Methods We will search for reports of RCTs published within two years in 25 general medical journals with the highest impact factor according to the Journal Citation Report (JCR)-2010. Teams of two reviewers will determine eligibility and extract relevant information from eligible RCTs in duplicate and using standardized forms. We will report the prevalence of DUR trials, the reported reasons for using DUR, and perform a linear regression analysis to estimate the association between the randomization ratio and the associated factors, including participation rate, type of informed consent, clinical area, and so on. Discussion A clearer understanding of RCTs with DUR and its association with factors in trials, for example, participation rate, can optimize trial design and may have important implications for both researchers and users of the medical literature.
- Published
- 2014
16. Aberrant splicing and drug resistance in AML.
- Author
-
de Necochea-Campion, Rosalia, Shouse, Geoffrey P., Qi Zhou, Mirshahidi, Saied, and Chien-Shing Chen
- Subjects
DRUG resistance ,ACUTE myeloid leukemia ,SPLICEOSOMES ,TUMOR suppressor genes ,ONCOGENES - Abstract
The advent of next-generation sequencing technologies has unveiled a new window into the heterogeneity of acute myeloid leukemia (AML). In particular, recurrent mutations in spliceosome machinery and genome-wide aberrant splicing events have been recognized as a prominent component of this disease. This review will focus on how these factors influence drug resistance through altered splicing of tumor suppressor and oncogenes and dysregulation of the apoptotic signaling network. A better understanding of these factors in disease progression is necessary to design appropriate therapeutic strategies recognizing specific alternatively spliced or mutated oncogenic targets. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
17. Intrinsic and extrinsic goals as moderators of stress and depressive symptoms in Chinese undergraduate students: A multi-wave longitudinal study.
- Author
-
Yu Ling, Yushu He, Yong Wei, Weihong Cen, Qi Zhou, and Mingtian Zhong
- Subjects
PSYCHOLOGICAL stress ,MENTAL depression ,UNDERGRADUATES ,PSYCHIATRISTS ,HEALTH - Abstract
Background: Studies in western countries have examined the specific vulnerability hypothesis of Dykman's theory of goal-orientation predispositions to depression through two-time point designs. The purpose of this prospective longitudinal study was to investigate the moderating effects of intrinsic and extrinsic goals on stress and depressive symptoms in Chinese undergraduate students. Methods: A total of 462 undergraduate students [46 % female; mean age, 19.06 (range, 17-22) years] completed self-reported measures assessing intrinsic and extrinsic goals, depressive symptoms, and the occurrence of social and academic hassles. Every 3 months over the subsequent 12 months, the undergraduate students completed measures assessing depressive symptoms and the occurrence of daily hassles. Results: Results of hierarchical linear modeling analyses indicated that undergraduate students with low levels of intrinsic goals reported greater depressive symptoms following the occurrence of social and academic hassles than did those with high levels of such goals. However, undergraduate students with high levels of extrinsic goals did not report greater depressive symptoms following the occurrence of social and academic hassles than did those possessing low levels. Conclusions: These findings suggest that intrinsic goals can protect undergraduate students experiencing high levels of social and academic hassles from depressive symptoms. The study findings provide new insight into the course of depressive symptoms among undergraduate students, and offer psychologist and psychiatrists ways to protect individuals from depressive symptoms by building up intrinsic goals. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
18. Enhancement of anti-tumor effects of 5-fluorouracil on hepatocellular carcinoma by low-intensity ultrasound.
- Author
-
Zheng Hu, Guixiang Lv, Yongning Li, Enze Li, Haixia Li, Qi Zhou, Bin Yang, and Wenwu Cao
- Subjects
FLUOROURACIL ,LIVER cancer ,ULTRASONIC imaging ,CANCER chemotherapy ,DRUG therapy - Abstract
Background: Hepatocellular carcinoma (HCC) accounts for 75 % of liver cancers and is the second most lethal cancer, associated with its multiple etiologies, poor prognosis and resistance to chemotherapy drugs. Chemotherapy treatment on HCC suffers low efficacy of drug uptake and can produce a range of side effects. Here we report an investigation on the effect of a combined treatment on human hepatocellular carcinoma BEL-7402 cells using low-intensity ultrasound (US) and 5-fluorouracil (5-FU). Methods: The uptake of 5-FU was measured by the high-performance liquid chromatography (HPLC). DNA damage was detected by the comet assay. MTT assay was used to examine cell viability. Intracellular reactive oxygen species (ROS) and mitochondrial membrane potential (Δψm) were respectively detected by the fluorescent probes DCFH-DA or JC-1. Endogenous apoptosis-associated proteins were analyzed by the western blot and immunohistochemistry. Histopathological changes were evaluated by the hematoxylin and eosin (H&E) staining. Cell apoptosis was evaluated by the TUNEL and flow cytometry assays. Cell proliferation was measured using the immunohistochemical staining of PCNA. Results: Our results showed that low-intensity US (1.1 MHz, 1.0 W/cm
2 , 10 % duty cycle) significantly enhanced the uptake of 5-FU, 5-FU-mediated DNA damage and reactive oxygen species (ROS) generation. The increased ROS production up-regulated the p53 protein level, which led to the up-regulation of Bax and down-regulation of Bcl-2. The enhancement of ROS generation and the activation of the apoptosis-associated proteins further triggered the collapse of mitochondrial membrane potential, released cytochrome c from mitochondria into cytosol and activated the mitochondria-caspase pathway, and cell apoptosis. Such enhanced effects could be partially blocked by the ROS scavenger N-acetylcysteine (NAC). Overall, low-intensity US combined with 5-FU led to an effective inhibition of tumor growth and prolonged overall survival of BEL-7402 HCC-bearing nude mice by more than 15 % compared with 5-FU treatment alone. Conclusions: Our results showed that low-intensity ultrasound combined with 5-FU produced much enhanced synergistic anti-tumor effects via enhanced ROS production in treating HCC. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
19. Initiation and continuation of randomized trials after the publication of a trial stopped early for benefit asking the same study question: STOPIT-3 study design
- Author
-
Gerard Urrútia, Lorenzo Moja, Joerg J Meerpohl, Annette Kristiansen, Martin A. Walter, Paul Glasziou, Elie A. Akl, Kristian Thorlund, Patricia J. Erwin, Gordon H. Guyatt, Dirk Bassler, Matthias Briel, Osama Qasim-Agha, Regina Kunz, Jason W. Busse, Hector Pardo-Hernandez, Pablo Alonso Coello, Gabriela Prutsky, Gennaro Pagano, Mohammad Hassan Murad, Victor M. Montori, Benjamin Kasenda, Stephen D. Walter, Stefan Schandelmaier, Xin Sun, Ignacio Ferreira-González, Juan Pablo Domecq, and Qi Zhou
- Subjects
Research design ,medicine.medical_specialty ,Time Factors ,conflict of interest ,Alternative medicine ,Medicine (miscellaneous) ,610 Medicine & health ,data extraction ,law.invention ,Continuation ,Study Protocol ,sensitivity analysis ,Randomized controlled trial ,law ,medicine ,Relative magnitude ,Protocol ,purl.org/pe-repo/ocde/ford#1.06.02 [https] ,Humans ,Pharmacology (medical) ,randomized controlled trial (topic) ,Randomized controlled trials stopped early for benefit ,Randomized Controlled Trials as Topic ,Evidence-Based Medicine ,business.industry ,Information Dissemination ,article ,Evidence-based medicine ,journal impact factor ,publication ,clinical research ,Research Design ,Early Termination of Clinical Trials ,Physical therapy ,Systematic review ,Periodicals as Topic ,business ,RCT ,controlled vocabulary - Abstract
Background Randomized control trials (RCTs) stopped early for benefit (truncated RCTs) are increasingly common and, on average, overestimate the relative magnitude of benefit by approximately 30%. Investigators stop trials early when they consider it is no longer ethical to enroll patients in a control group. The goal of this systematic review is to determine how investigators of ongoing or planned RCTs respond to the publication of a truncated RCT addressing a similar question. Methods/design We will conduct systematic reviews to update the searches of 210 truncated RCTs to identify similar trials ongoing at the time of publication, or started subsequently, to the truncated trials ('subsequent RCTs’). Reviewers will determine in duplicate the similarity between the truncated and subsequent trials. We will analyze the epidemiology, distribution, and predictors of subsequent RCTs. We will also contact authors of subsequent trials to determine reasons for beginning, continuing, or prematurely discontinuing their own trials, and the extent to which they rely on the estimates from truncated trials. Discussion To the extent that investigators begin or continue subsequent trials they implicitly disagree with the decision to stop the truncated RCT because of an ethical mandate to administer the experimental treatment. The results of this study will help guide future decisions about when to stop RCTs early for benefit.
- Published
- 2013
- Full Text
- View/download PDF
20. OA07.02. Naturopathic medicine for the prevention of cardiovascular disease: a pragmatic randomized clinical trial
- Author
-
Orest Szczurko, David Lescheid, C Herrington, G. H. Guyatt, Ryan Bradley, Qi Zhou, Bob Bernhardt, D Seely, Heidi Fritz, T Gignac, Philip Rouchotas, C Kieran, S Aberdour, and Patricia M. Herman
- Subjects
0106 biological sciences ,medicine.medical_specialty ,Naturopathy ,Alternative medicine ,Disease ,01 natural sciences ,law.invention ,Randomized controlled trial ,law ,medicine ,Framingham Risk Score ,010405 organic chemistry ,business.industry ,Incidence (epidemiology) ,General Medicine ,lcsh:Other systems of medicine ,medicine.disease ,lcsh:RZ201-999 ,3. Good health ,0104 chemical sciences ,Complementary and alternative medicine ,Family medicine ,Relative risk ,Oral Presentation ,Metabolic syndrome ,business ,010606 plant biology & botany - Abstract
Methods Multi-site pragmatic randomized controlled trial of enhanced usual care (EUC; usual care plus biometric screening) versus EUC plus naturopathic care (EUC +NC). NC consisted of individualized care provided in work-site clinics by licensed naturopathic doctors (NDs) utilizing one or more of the following strategies: lifestyle counseling, nutritional medicine, and/or dietary supplementation. EUC consisted of usual care provided by the participant’s family physician in the community following identification as having a higher relative risk of developing cardiovascular disease. Primary outcomes were incidence of metabolic syndrome and 10-year risk of having a cardiovascular event based on the Framingham algorithm and the Adult Treatment Panel (ATP) III diagnostic criteria for metabolic syndrome.
- Published
- 2012
21. Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions.
- Author
-
Juan Wang, Jie Hao, Donghui Bai, Qi Gu, Weifang Han, Lei Wang, Yuanqing Tan, Xia Li, Ke Xue, Pencheng Han, Zhengxin Liu, Yundan Jia, Jun Wu, Lei Liu, Liu Wang, Wei Li, Zhonghua Liu, and Qi Zhou
- Subjects
PLURIPOTENT stem cells ,REGENERATIVE medicine ,CLINICAL trials ,FIBROBLASTS ,CELL culture - Abstract
Introduction: Human induced pluripotent stem cells (hiPSCs) are considered as one of the most promising seed cell sources in regenerative medicine. Now hiPSC-based clinical trials are underway. To ensure clinical safety, cells used in clinical trials or therapies should be generated under GMP conditions, and with Xeno-free culture media to avoid possible side effects like immune rejection that induced by the Xeno reagents. However, up to now there are no reports for hiPSC lines developed completely under GMP conditions using Xeno-free reagents. Methods: Clinical-grade human foreskin fibroblast (HFF) cells used as feeder cells and parental cells of the clinical-grade hiPSCs were isolated from human foreskin tissues and cultured in Xeno-free media. Clinical-grade hiPSCs were derived by integration-free Sendai virus-based reprogramming kit in Xeno-free pluriton™ reprogramming medium or X medium. Neural cells and cardiomyocytes differentiation were conducted following a series of spatial and temporal specific signals induction according to the corresponding lineage development signals. Biological safety evaluation of the clinical-grade HFF cells and hiPSCs were conducted following the guidance of the "Pharmacopoeia of the People's Republic of China, Edition 2010, Volume III". Results: We have successfully derived several integration-free clinical-grade hiPSC lines under GMP-controlled conditions and with Xeno-free reagents culture media in line with the current guidance of international and national evaluation criteria. As for the source of hiPSCs and feeder cells, biological safety evaluation of the HFF cells have been strictly reviewed by the National Institutes for Food and Drug Control (NIFDC). The hiPSC lines are pluripotent and have passed the safety evaluation. Moreover, one of the randomly selected hiPSC lines was capable of differentiating into functional neural cells and cardiomyocytes in Xeno-free culture media. Conclusion: The clinical-grade hiPSC lines therefore could be valuable sources for future hiPSC-based clinical trials or therapies and for drug screening. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
22. Downregulation of ASPP2 in pancreatic cancer cells contributes to increased resistance to gemcitabine through autophagy activation.
- Author
-
Bin Song, Qi Bian, Yi-Jie Zhang, Cheng-Hao Shao, Gang Li, An-An Liu, Wei Jing, Rui Liu, Ying-Qi Zhou, Gang Jin, and Xian-Gui Hu
- Subjects
APOPTOSIS ,APOPTOSIS inhibition ,AUTOPHAGY ,VESICLES (Cytology) ,GENE therapy ,CANCER treatment ,PHYSIOLOGY - Abstract
Background: Apoptosis-stimulating of p53 protein 2 (ASPP2) is one of the ASPP family members and it has been reported to be associated with human cancer. However, the role of it in pancreatic cancer is still not clear. Methods: We analyzed the expression level of ASPP2 in cancer tissue samples with RT-qPCR, Western Blotting assay and immunohistochemistry staining. We studied the biological function of ASPP2 and its mechanism with gene overexpression and gene silencing technologies. We determined the sensitivity of pancreatic cells with differential ASPP2 level to gemcitabine and whether autophagy inhibition affected the gemcitabine resistance, both in vitro and in vivo. Results: Expression of ASPP2 was downregulated in cancerous tissues in comparison with para-cancerous tissues. ASPP2 expression was linked to clinical outcomes in patients and down-regulation of ASPP2 increased cell proliferation, autophagic flux, the activity of AMP Kinase of pancreatic cancer cells and vice versa. Knockdown of ASPP2 results in increased resistance to gemcitabine, which was attributed to the enhanced autophagy. Conclusions: ASSP2 expression is lower in cancerous tissues and decreased ASPP2 lead to higher cancer cells proliferation and autophagic flux, which contribute to the gemcitabine resistance. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
23. A practical guideline for intracranial volume estimation in patients with Alzheimer's disease.
- Author
-
Sargolzaei, Saman, Sargolzaei, Arman, Cabrerizo, Mercedes, Gang Chen, Goryawala, Mohammed, Shirin Noei, Qi Zhou, Duara, Ranjan, Barker, Warren, and Adjouadi, Malek
- Subjects
ALZHEIMER'S disease ,MAGNETIC resonance imaging ,MORPHOMETRICS ,COGNITIVE ability ,DIAGNOSTIC imaging - Abstract
Background: Intracranial volume (ICV) is an important normalization measure used in morphometric analyses to correct for head size in studies of Alzheimer Disease (AD). Inaccurate ICV estimation could introduce bias in the outcome. The current study provides a decision aid in defining protocols for ICV estimation in patients with Alzheimer disease in terms of sampling frequencies that can be optimally used on the volumetric MRI data, and the type of software most suitable for use in estimating the ICV measure. Methods: Two groups of 22 subjects are considered, including adult controls (AC) and patients with Alzheimer Disease (AD). Reference measurements were calculated for each subject by manually tracing intracranial cavity by the means of visual inspection. The reliability of reference measurements were assured through intra- and intervariation analyses. Three publicly well-known software packages (Freesurfer, FSL, and SPM) were examined in their ability to automatically estimate ICV across the groups. Results: Analysis of the results supported the significant effect of estimation method, gender, cognitive condition of the subject and the interaction among method and cognitive condition factors in the measured ICV. Results on sub-sampling studies with a 95% confidence showed that in order to keep the accuracy of the interleaved slice sampling protocol above 99%, the sampling period cannot exceed 20 millimeters for AC and 15 millimeters for AD. Freesurfer showed promising estimates for both adult groups. However SPM showed more consistency in its ICV estimation over the different phases of the study. Conclusions: This study emphasized the importance in selecting the appropriate protocol, the choice of the sampling period in the manual estimation of ICV and selection of suitable software for the automated estimation of ICV. The current study serves as an initial framework for establishing an appropriate protocol in both manual and automatic ICV estimations with different subject populations. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
24. Temporal genomic evolution of bird sex chromosomes.
- Author
-
Zongji Wang, Jilin Zhang, Wei Yang, Na An, Pei Zhang, Guojie Zhang, and Qi Zhou
- Subjects
SEX chromosomes ,EVOLUTIONARY theories ,GENE expression ,GENETIC drift ,TRANSCRIPTOMES - Abstract
Background: Sex chromosomes exhibit many unusual patterns in sequence and gene expression relative to autosomes. Birds have evolved a female heterogametic sex system (male ZZ, female ZW), through stepwise suppression of recombination between chrZ and chrW. To address the broad patterns and complex driving forces of Z chromosome evolution, we analyze here 45 newly available bird genomes and four species' transcriptomes, over their course of recombination loss between the sex chromosomes. Results: We show Z chromosomes in general have a significantly higher substitution rate in introns and synonymous protein-coding sites than autosomes, driven by the male-to-female mutation bias (‘male-driven evolution' effect). Our genome-wide estimate reveals that the degree of such a bias ranges from 1.6 to 3.8 among different species. G + C content of third codon positions exhibits the same trend of gradual changes with that of introns, between chrZ and autosomes or regions with increasing ages of becoming Z-linked, therefore codon usage bias in birds is probably driven by the mutational bias. On the other hand, Z chromosomes also evolve significantly faster at nonsynonymous sites relative to autosomes (‘fast-Z' evolution). And species with a lower level of intronic heterozygosities tend to evolve even faster on the Z chromosome. Further analysis of fast-evolving genes' enriched functional categories and sex-biased expression patterns support that, fast-Z evolution in birds is mainly driven by genetic drift. Finally, we show in species except for chicken, gene expression becomes more male-biased within Z-linked regions that have became hemizygous in females for a longer time, suggesting a lack of global dosage compensation in birds, and the reported regional dosage compensation in chicken has only evolved very recently. Conclusions: In conclusion, we uncover that the sequence and expression patterns of Z chromosome genes covary with their ages of becoming Z-linked. In contrast to the mammalian X chromosomes, such patterns are mainly driven by mutational bias and genetic drift in birds, due to the opposite sex-biased inheritance of Z vs. X. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
25. Optimized rapeseed oils rich in endogenous micronutrients ameliorate risk factors of atherosclerosis in high fat diet fed rats.
- Author
-
Jiqu Xu, Congcong Ma, Ling Han, Hui Gao, Qi Zhou, Mei Yang, Chang Chen, Qianchun Deng, Qingde Huang, and Fenghong Huang
- Subjects
RAPESEED oil ,MICRONUTRIENTS ,ATHEROSCLEROSIS risk factors ,HIGH-fat diet ,LABORATORY rats - Abstract
Background: Micronutrients in rapeseed such as polyphenols, tocopherols, phytosterols and phospholipids in rapeseed exert potential benefit to atherosclerosis. Some part of these healthy components substantially lost during the conventional refining processing. Thus some new processing technologies have been developed to produce various endogenous micronutrient-enriched optimized rapeseed oils. The aim of this study is to assess whether optimized rapeseed oils have positive effects on the atherosclerosis risk factors in rats fed a high-fat diet. Methods: Rats received experiment diets containing 20% fat and refined rapeseed oil or optimized rapeseed oils obtained with various processing technologies as lipid source. After 10 weeks of treatment, plasma was assayed for oxidative stress, lipid profiles and imflammation. Results: Micronutrients enhancement in optimized rapeseed oils significantly reduced plasma oxidative stress, as evaluated by the significant elevation in the activities of CAT and GPx as well as the level of GSH, and the significant decline in lipid peroxidation. Optimized rapeseed oil with the highest micronutrient contents obtained by microwave pretreatment-cold pressing reduced the levels of TG, TC and LDL-C as well as IL-6 and CRP in plasma. Conclusions: These results suggest that optimized rapeseed oils may contribute to prevent atherogenesis and make them very promising functional food in cardiovascular health promotion. [ABSTRACT FROM AUTHOR]
- Published
- 2014
26. Serum B7-H4 expression is a significant prognostic indicator for patients with gastric cancer.
- Author
-
Hongbing Shi, Mei Ji, Jun Wu, Qi Zhou, Xiaodong Li, Zhengguang Li, Xiao Zheng, Bing Xu, Weiqing Zhao, Changping Wu, and Jingting Jiang
- Subjects
GENE expression ,LIGANDS (Biochemistry) ,GASTRIC diseases ,MULTIVARIATE analysis ,CANCER patients ,DISEASE progression - Abstract
Background B7-H4 is a novel B7 ligand that plays an important role in the T cell-mediated immune response as a negative regulator. Previous studies have suggested the aberrant expression of membrane B7-H4 in tumor cells. The aim of this study is to determine the expression levels of preoperative soluble B7-H4 (sB7-H4) in circulation and to investigate the correlations between sB7-H4 levels and clinicopathological parameters as well as the survival rate of patients with gastric cancer. Methods Blood specimens from 132 patients with gastric cancer and 63 healthy volunteers were analyzed by sandwich enzyme-linked immunosorbent assay. Results Median concentrations of sB7-H4 in patients with gastric cancer were significantly higher than those in healthy volunteers (16.85 versus 10.46 ng/mL; P = 0.008). Median levels of sB7-H4 were significantly correlated with tumor size, lymph node metastasis, the depth of tumor invasion and tumor-node-metastasis classification (P = 0.002, P = 0.001, P = 0.041 and P <0.001, respectively), but not with sex, age, tumor location or histological subtype (all P >0.05). Additionally, the overall survival rate was significantly lower in patients with high sB7-H4 levels when compared with low sB7-H4 levels (50.0% versus 77.3%, X
2 = 10.78, P = 0.001). Moreover, multivariate analysis demonstrated that the risk of death was significantly higher in patients with high sB7-H4 levels than in those with low sB7-H4 levels (P = 0.039). Conclusions sB7-H4 is a valuable blood marker for predicting the progression and prognosis of patients with gastric cancer. [ABSTRACT FROM AUTHOR]- Published
- 2014
- Full Text
- View/download PDF
27. Haploid embryonic stem cells serve as a new tool for mammalian genetic study.
- Author
-
Ling Shuai and Qi Zhou
- Abstract
In mammals, all somatic cells carry two sets of chromosomes while haploids are restricted only to gametes and are occasionally found in tumors with genome instability. Mammalian haploid embryonic stem (ES) cells have recently been established successfully in mice and monkeys, from either parthenogenetic or androgenetic haploid embryos. These haploid ES cells maintain haploidy and stable growth during extensive in vitro culture, express pluripotent markers, and possess the ability to differentiate into all three germ layers in vitro and in vivo. The mouse haploid ES cells can also contribute to germlines of chimeras. Moreover, the mouse androgenetic haploid ES cells can produce fertile progenies after intracytoplasmic injection into mature oocytes, and the mouse parthenogenetic haploid ES cells can also achieve this by substitution of the maternal genome, albeit at a lower efficiency. These distinct features of mammalian haploid ES cells empower themselves not only as a valuable tool for genetic screening at a cellular level, but also as a new tool for genome-modified animal production and genetic studies at the animal level. Here we review the current progress on mammalian haploid ES cell research, describe in detail their characteristics, and discuss their potential applications. These achievements may provide a new but powerful tool for mammalian genetic studies, and may also shed light on the some interesting questions regarding genome ploidy maintenance and genomic imprinting. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
28. Methodological survey of designed uneven randomization trials (DU-RANDOM): a protocol.
- Author
-
Darong Wu, Akl, Elie A., Guyatt, Gordon H., Devereaux, Philip J., Petersen, Romina Brignardello, Prediger, Barbara, Patel, Krupesh, Patel, Namrata, Taoying Lu, Yuan Zhang, Falavigna, Maicon, Santesso, Nancy, Mustafa, Reem A., Qi Zhou, Briel, Matthias, and Schünemann, Holger J.
- Subjects
RANDOMIZED controlled trials ,CLINICAL trials ,MEDICAL journalism ,PARTICIPATION - Abstract
Background Although even randomization (that is, approximately 1:1 randomization ratio in study arms) provides the greatest statistical power, designed uneven randomization (DUR), (for example, 1:2 or 1:3) is used to increase participation rates. Until now, no convincing data exists addressing the impact of DUR on participation rates in trials. The objective of this study is to evaluate the epidemiology and to explore factors associated with DUR. Methods We will search for reports of RCTs published within two years in 25 general medical journals with the highest impact factor according to the Journal Citation Report (JCR)-2010. Teams of two reviewers will determine eligibility and extract relevant information from eligible RCTs in duplicate and using standardized forms. We will report the prevalence of DUR trials, the reported reasons for using DUR, and perform a linear regression analysis to estimate the association between the randomization ratio and the associated factors, including participation rate, type of informed consent, clinical area, and so on. Discussion A clearer understanding of RCTs with DUR and its association with factors in trials, for example, participation rate, can optimize trial design and may have important implications for both researchers and users of the medical literature. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
29. Initiation and continuation of randomized trials after the publication of a trial stopped early for benefit asking the same study question: STOPIT-3 study design.
- Author
-
Prutsky, Gabriela J., Domecq, Juan Pablo, Erwin, Patricia J., Briel, Matthias, Montori, Victor M., Akl, Elie A., Meerpohl, Joerg J., Bassler, Dirk, Schandelmier, Stefan, Walter, Stephen D., Qi Zhou, Coello, Pablo Alonso, Moja, Lorenzo, Walter, Martin, Thorlund, Kristian, Glasziou, Paul, Kunz, Regina, Ferreira-Gonzalez, Ignacio, Busse, Jason, and Xin Sun
- Subjects
CLINICAL trials ,SYSTEMATIC reviews ,PUBLIC health ,INFECTIOUS disease transmission ,EPIDEMIOLOGY - Abstract
Background Randomized control trials (RCTs) stopped early for benefit (truncated RCTs) are increasingly common and, on average, overestimate the relative magnitude of benefit by approximately 30%. Investigators stop trials early when they consider it is no longer ethical to enroll patients in a control group. The goal of this systematic review is to determine how investigators of ongoing or planned RCTs respond to the publication of a truncated RCT addressing a similar question. Methods/design We will conduct systematic reviews to update the searches of 210 truncated RCTs to identify similar trials ongoing at the time of publication, or started subsequently, to the truncated trials ('subsequent RCTs'). Reviewers will determine in duplicate the similarity between the truncated and subsequent trials. We will analyze the epidemiology, distribution, and predictors of subsequent RCTs. We will also contact authors of subsequent trials to determine reasons for beginning, continuing, or prematurely discontinuing their own trials, and the extent to which they rely on the estimates from truncated trials. Discussion To the extent that investigators begin or continue subsequent trials they implicitly disagree with the decision to stop the truncated RCT because of an ethical mandate to administer the experimental treatment. The results of this study will help guide future decisions about when to stop RCTs early for benefit [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
30. The roles of Notch1 expression in the migration of intrahepatic cholangiocarcinoma.
- Author
-
Qi Zhou, Yafeng Wang, Baogang Peng, Lijian Liang, Jiaping Li, Zhou, Qi, Wang, Yafeng, Peng, Baogang, Liang, Lijian, and Li, Jiaping
- Subjects
- *
NOTCH genes , *NEOPLASTIC cell transformation , *CHOLANGIOCARCINOMA , *CELL migration , *GENE transfection , *WESTERN immunoblotting - Abstract
Background: Notch signaling, a critical pathway for tissue development, contributes to tumorigenesis in many tissues; however, the roles of Notch signaling in Intrahepatic Cholangiocarcinoma (ICC) remains unclear. In this study, we evaluated the expression and effects of Notch1 on cell migration in ICC.Methods: Multiple cellular and molecular approaches were performed including gene transfection, siRNA transfection, RT-PCR, Western blotting, Rac activation assays and immunofluorescence.Results: We found that Notch1 was up-regulated in ICC tissues and cell lines. The exogenous expression of Notch1 in glioma cells increased their migratory and invasive capacity. Similarly, the suppression of Notch1 expression inactivated Rac1 and inhibited ICC cell migration. Notch1 over expression induced an Epithelial-to-mesenchymal transition (EMT) phenotype that included enhanced expression of α-SMA and Vimentin, loss of E-cadherin expression, morphological changes and cytoskeletal reorganization in ICC cells.Conclusion: Notch1 may induce a migratory effect in ICC by causing an epithelial-mesenchymal transition and activating Rac1 and could serve as a novel diagnostic and therapeutic target in patients with ICC. [ABSTRACT FROM AUTHOR]- Published
- 2013
- Full Text
- View/download PDF
31. Viewing the difference between the diploid and the polyploid in the light of the upland cotton aneuploid.
- Author
-
Shi-Qi Zhou
- Subjects
POLYPLOIDY ,ANEUPLOIDY ,COTTON ,MEIOSIS ,BIOLOGICAL adaptation - Abstract
The aneuploidy of Gossypium hirsutum L. (upland cotton) aneusomatics were obtained by induced parthenogenesis. These aneuploids could grow and set seeds normally. In the process of meiosis there appeared large quantities of heteromorphic pairs and multivalent chromosomes and many cases of cytomixis and multisperm fertilization occurred. The aneuploids produced offsprings through sexual propagation. We explored penetratingly the questions how and why these aneuploids could survive. Through this research, we found that the upland cotton possessed an immense latent capacity to adapt to adverse environments. More importantly, in the case of the upland cotton, we discovered that the genetic pattern of the polyploid differs in some respects from that of the diploid. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
32. Nuclear transfer: Progress and quandaries.
- Author
-
Xuemei Li, Ziyi Li, Jouneau, Alice, Qi Zhou, and Renard, Jean-Paul
- Subjects
TRANSPLANTATION of cell nuclei ,SOMATIC cells ,REPRODUCTIVE health ,EMBRYOLOGY ,ENDOCRINOLOGY ,BIOLOGY - Abstract
Cloning mammals by nuclear transfer is a powerful technique that is quickly advancing the development of genetically defined animal models. However, the overall efficiency of nuclear transfer is still very low and several hurdles remain before the power of this technique will be fully harnessed. Among these hurdles include an incomplete understanding of biologic processes that control epigenetic reprogramming of the donor genome following nuclear transfer. Incomplete epigenetic reprogramming is considered the major cause of the developmental failure of cloned embryos and is frequently associated with the disregulation of specific genes. At present, little is known about the developmental mechanism of reconstructed embryos. Therefore, screening strategies to design nuclear transfer protocols that will mimic the epigenetic remodeling occurring in normal embryos and identifying molecular parameters that can assess the developmental potential of pre-implantation embryos are becoming increasingly important. A crucial need at present is to understand the molecular events required for efficient reprogramming of donor genomes after nuclear transfer. This knowledge will help to identify the molecular basis of developmental defects seen in cloned embryos and provide methods for circumventing such problems associated with cloning the future application of this technology. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.